Results 141 to 150 of about 5,359 (232)

Shifts in the number of pityriasis rosea diagnoses during the COVID-19 pandemic: Insights on a viral etiology?

, 2022
Harrison Zhu, Vicky Ren
openalex   +2 more sources

The clinics of HHV ‐6 infection in COVID ‐19 pandemic: Pityriasis rosea and Kawasaki disease [PDF]

, 2020
Recep Dursun, Selami Aykut Temiz
openalex   +1 more source

The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations. [PDF]

Dermatol Ther, 2022
Ciccarese G, Parodi A, Drago F.
europepmc   +1 more source

Acute myelomonocytic leukemia presenting as a benign-appearing cutaneous eruption [PDF]

, 1990
Cole, John T., Horlick, Howard P., Knobler, Elizabeth H., Silvers, David N.   +3 more
core   +1 more source

Atypical Rash as a Presentation of Pityriasis Rosea in a 23-Month-Old. [PDF]

Cureus
Tilak K, Ray E, Joseph M.
europepmc   +1 more source

Pityriasis rosea-like drug eruption secondary to deucravacitinib. [PDF]

JAAD Case Rep
Punchihewa N, Lee S, Tan CG, Foley P.
europepmc   +1 more source

Infectueuze pathologie in de kinderdermatologie [PDF]

, 2010
Batteauw, Anneleen, De Schepper, Sofie, Lambert, Jo   +2 more
core   +1 more source

Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features. [PDF]

Viruses
Drago F, Herzum A, Varesano S, Serviddio G, Broccolo F, Ciccarese G.   +5 more
europepmc   +1 more source

comment: Does pityriasis rosea Koebnerise? [PDF]

, 2013
Antonio Chuh, Vijay Zawar
openalex   +1 more source

Pityriasis Rosea and Immunosuppressive Drugs [Letter]. [PDF]

Clin Cosmet Investig Dermatol
Drago F, Fidanzi C, Ciccarese G.
europepmc   +1 more source